Shares of Phibro Animal Health Corp (NASDAQ:PAHC) have earned an average rating of “Hold” from the six ratings firms that are covering the firm, MarketBeat Ratings reports. Three investment analysts have rated the stock with a sell recommendation, one has issued a hold recommendation and two have assigned a buy recommendation to the company. The average 12 month price objective among brokerages that have issued a report on the stock in the last year is $37.33.

PAHC has been the subject of several research reports. Bank of America reiterated an “underperform” rating and set a $33.00 price objective on shares of Phibro Animal Health in a research note on Wednesday, August 23rd. Zacks Investment Research downgraded shares of Phibro Animal Health from a “hold” rating to a “sell” rating in a research note on Wednesday, November 8th. BidaskClub downgraded shares of Phibro Animal Health from a “hold” rating to a “sell” rating in a research note on Saturday, December 2nd. Piper Jaffray Companies set a $42.00 price objective on shares of Phibro Animal Health and gave the stock a “buy” rating in a research note on Friday, August 25th. Finally, ValuEngine downgraded shares of Phibro Animal Health from a “buy” rating to a “hold” rating in a research note on Thursday, November 9th.

Shares of Phibro Animal Health (PAHC) opened at $32.65 on Friday. The company has a debt-to-equity ratio of 1.91, a quick ratio of 1.85 and a current ratio of 3.26. Phibro Animal Health has a 52 week low of $26.10 and a 52 week high of $40.25. The stock has a market cap of $1,340.10, a P/E ratio of 21.80, a price-to-earnings-growth ratio of 3.91 and a beta of 1.27.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings data on Monday, November 6th. The company reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.01. Phibro Animal Health had a net margin of 8.87% and a return on equity of 42.75%. The company had revenue of $193.40 million during the quarter, compared to the consensus estimate of $189.89 million. During the same period in the previous year, the firm earned $0.36 earnings per share. Phibro Animal Health’s revenue for the quarter was up 2.9% on a year-over-year basis. sell-side analysts predict that Phibro Animal Health will post 1.57 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 27th. Stockholders of record on Wednesday, December 6th will be given a dividend of $0.10 per share. The ex-dividend date of this dividend is Tuesday, December 5th. This represents a $0.40 dividend on an annualized basis and a dividend yield of 1.23%. Phibro Animal Health’s payout ratio is currently 23.53%.

In other news, insider Dean J. Warras sold 10,000 shares of the business’s stock in a transaction on Friday, September 15th. The shares were sold at an average price of $35.70, for a total transaction of $357,000.00. Following the transaction, the insider now directly owns 10,000 shares of the company’s stock, valued at $357,000. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CFO Richard G. Johnson sold 15,900 shares of the business’s stock in a transaction on Wednesday, September 13th. The stock was sold at an average price of $36.46, for a total transaction of $579,714.00. Following the transaction, the chief financial officer now directly owns 15,900 shares in the company, valued at $579,714. The disclosure for this sale can be found here. Over the last three months, insiders have sold 217,525 shares of company stock worth $7,900,197. Corporate insiders own 51.88% of the company’s stock.

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. lifted its position in shares of Phibro Animal Health by 3.0% during the second quarter. Vanguard Group Inc. now owns 1,780,880 shares of the company’s stock worth $65,982,000 after purchasing an additional 51,474 shares in the last quarter. FMR LLC raised its holdings in Phibro Animal Health by 31.9% in the second quarter. FMR LLC now owns 584,463 shares of the company’s stock valued at $21,654,000 after acquiring an additional 141,274 shares in the last quarter. State Street Corp raised its holdings in Phibro Animal Health by 6.1% in the first quarter. State Street Corp now owns 489,093 shares of the company’s stock valued at $13,745,000 after acquiring an additional 28,273 shares in the last quarter. Dimensional Fund Advisors LP raised its holdings in Phibro Animal Health by 11.8% in the third quarter. Dimensional Fund Advisors LP now owns 465,297 shares of the company’s stock valued at $17,239,000 after acquiring an additional 49,296 shares in the last quarter. Finally, Ameriprise Financial Inc. raised its holdings in Phibro Animal Health by 26.7% in the third quarter. Ameriprise Financial Inc. now owns 430,656 shares of the company’s stock valued at $15,958,000 after acquiring an additional 90,660 shares in the last quarter. 48.42% of the stock is currently owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: “Phibro Animal Health Corp (PAHC) Receives Consensus Recommendation of “Hold” from Analysts” was first published by American Banking News and is the property of of American Banking News. If you are accessing this story on another site, it was stolen and reposted in violation of US & international trademark and copyright law. The original version of this story can be read at https://www.americanbankingnews.com/2017/12/08/phibro-animal-health-corp-pahc-receives-consensus-recommendation-of-hold-from-analysts.html.

About Phibro Animal Health

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Receive News & Ratings for Phibro Animal Health Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corp and related companies with MarketBeat.com's FREE daily email newsletter.